See also this year's filing and all EDGAR filings for this company.
PDF Report 0001745020_2023_Theseus_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001745020, Theseus Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 0 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 416,000 |
3 | remainder_Assets | 222,031,000 |
4 | LiabilitiesCurrent | 11,130,000 |
5 | LiabilitiesNoncurrent | 3,236,000 |
6 | remainder_Liabilities | 466,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 18,388,000 |
9 | ResearchAndDevelopmentExpense | 35,698,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 3,478,000 |
13 | remainder_ComprehensiveNetIncome | -386,000 |
yvar | yval | |
---|---|---|
0 | Assets | 222,447,000 |
1 | Liabilities | 14,832,000 |
2 | Expenses | 54,086,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 207,615,000 |
5 | NetIncome | -50,608,000 |
6 | ComprehensiveNetIncome | -50,801,000 |
7 | BaseVar | 147,614,500 |
8 | EconomicCapitalRatio | 2.58 |